Tag archive for ‘AML’
Gil Tanenbaum On Wednesday, January 7th, 2015

Gamida Cell Gets FDA Orphan Drug Approval

Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that orphan drug designation has been granted by the FDA for its investigational More...

health ,cancer,
Jewish Business News Service On Tuesday, February 4th, 2014

Chemical Stem Cell Signature Predicts Respond To Chemotherapy For Acute Myeloid Leukemia

– Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical “signature” in blood-forming stem cells that predicts whether More...

Wordpress site Developed by Fixing WordPress Problems